Today I was catching up on reading some past American Family Physician journals, and in the July 1, 2017 issue are two excellent editorials addressing drug prices charged by pharmaceutical companies in the U.S. They are quick reads, free to anyone to access, and worth checking out:
Problematic Jumps in Drug Prices and What You Can Do. by Allen F Shaughnessy, PharmD, Tufts University School of Medicine.
A brief exerpt: “The industry also claims that revenue is plowed back into research and development… the major pharmaceutical companies spend more on sales and marketing ($5.2 billion in 2015) than they do on research and development.
Drug Price Gouging: When Will It End? by Jay Siwek, MD, Georgetown University Medical Center
This is a very brief, one column, scathing critique of drug pricing.